ROS/RNS As Molecular Signatures of Chronic Liver Diseases
Overview
Molecular Biology
Affiliations
The liver can succumb to oxidant damage during the development of chronic liver diseases. Despite their physiological relevance to hepatic homeostasis, excessive reactive oxygen/nitrogen species (ROS/RNS) production under pathological conditions is detrimental to all liver constituents. Chronic oxidative stress coupled to unresolved inflammation sets in motion the activation of profibrogenic hepatic stellate cells (HSCs) and later pathogenesis of liver fibrosis, cirrhosis, and liver cancer. The liver antioxidant and repair systems, along with autophagic and ferroptotic machineries, are implicated in the onset and trajectory of disease development. In this review, we discuss the ROS/RNS-related mechanisms underlying liver fibrosis of distinct etiologies and highlight preclinical and clinical trials of antifibrotic therapies premised on remediating oxidative/nitrosative stress in hepatocytes or targeting HSC activation.
Yu S, Wang Y, Shi Y, Yu S, Zhao B, Liao N Bioeng Transl Med. 2025; 10(2):e10735.
PMID: 40060764 PMC: 11883125. DOI: 10.1002/btm2.10735.
Chidebe E, Moke E, Asiwe J, Ben-Azu B, Demaki W, Oritsemuelebi B Int J Physiol Pathophysiol Pharmacol. 2025; 16(6):126-137.
PMID: 39850246 PMC: 11751547. DOI: 10.62347/PFXZ9903.
Uremis N, Uremis M J Biochem Mol Toxicol. 2025; 39(1):e70133.
PMID: 39799559 PMC: 11725306. DOI: 10.1002/jbt.70133.
Li D, Han H, Sun Y, Zhang H, Yoshitomi R, Kaul S Int J Mol Sci. 2024; 25(22).
PMID: 39596320 PMC: 11594306. DOI: 10.3390/ijms252212256.
Yang Z, Wong N, Mao F, Wu S, Yi W, Yu Z Antioxidants (Basel). 2024; 13(11).
PMID: 39594493 PMC: 11591149. DOI: 10.3390/antiox13111351.